Technologically Processed Highly Diluted Antibodies to S100 Protein in the Treatment of Neurotic Disorders: The Review
Neurotic disorders (NDs) are among the most common mental diseases leading to a decrease in the quality of life, lack of socialization, and increased mortality. The diagnosis and treatment of all types of NDs are challenging. In the light of the ongoing search for an effective and safe therapeutic s...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2020
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/71930 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Technologically Processed Highly Diluted Antibodies to S100 Protein in the Treatment of Neurotic Disorders: The Review
- Monoclonal Antibodies for Cancer Treatment
- NeuroTS-Net: Multi-Class Semantic Segmentation of Pediatric Brain Tumors in Multi-Modal MRI
- Emerging Monoclonal Antibodies for the Treatment of Multiple Myeloma
- Is Einstein more agreeable and less neurotic than Hitler? A computational exploration of the emotional and personality profiles of historical persons
- Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer
- Antibody DomainBed: Out-of-Distribution Generalization in Therapeutic Protein Design